| Original language | English |
|---|---|
| Pages (from-to) | 326-328 |
| Number of pages | 3 |
| Journal | Schizophrenia research |
| Volume | 210 |
| DOIs | |
| Publication status | Published - Aug 2019 |
All Science Journal Classification (ASJC) codes
- Psychiatry and Mental health
- Biological Psychiatry
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Cuprizone-treated mice, a possible model of schizophrenia, highlighting the simultaneous abnormalities of GABA, serine and glycine in hippocampus. / Hayakawa, Eisuke; Ohgidani, Masahiro; Fujimura, Yoshinori; Kanba, Shigenobu; Miura, Daisuke; Kato, Takahiro A.
In: Schizophrenia research, Vol. 210, 08.2019, p. 326-328.Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - Cuprizone-treated mice, a possible model of schizophrenia, highlighting the simultaneous abnormalities of GABA, serine and glycine in hippocampus
AU - Hayakawa, Eisuke
AU - Ohgidani, Masahiro
AU - Fujimura, Yoshinori
AU - Kanba, Shigenobu
AU - Miura, Daisuke
AU - Kato, Takahiro A.
N1 - Funding Information: This work was supported by a Grant-in-Aid for Scientific Research on (1) KAKENHI - the Japan Society for the Promotion of Science (to E.H.: 17K14968 ; to D. M.: 26713020 ; to T.A.K., M.O. and S.K.: 24650227 , 25293252 , 16H02666 , 26713039 , 26860933 , and 18H04042 ), (2) MEXT Funding-Project for Developing Innovation Systems Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program in Japan (D.M. and T. A. K.), (3) Innovative Areas “Glia Assembly” and “Will Dynamics” of The Ministry of Education, Culture, Sports, Science, and Technology, Japan ( 25117011 to S.K.; 16H06403 to T.A.K.), (4) The Japan Agency for Medical Research and Development (AMED) ( Yugo-Nou JP18dm0107095 to T.A.K.: Seishin-Syogai Taisaku-Jigyo JP18dk0307075 to S.K. and T.A.K.), (5) Young Principal Investigators' Research Grant of Innovation Center for Medical Redox Navigation, Kyushu University (to T.A.K.), (6) Takeda Medical Research Foundation (to T.A.K.), and (7) the SENSHIN Medical Research Foundation (to T.A.K., M.O., and S.K.). The funders had no role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript. Funding Information: This work was supported by a Grant-in-Aid for Scientific Research on (1) KAKENHI - the Japan Society for the Promotion of Science (to E.H.: 17K14968; to D. M.: 26713020; to T.A.K., M.O. and S.K.: 24650227, 25293252, 16H02666, 26713039, 26860933, and 18H04042), (2) MEXT Funding-Project for Developing Innovation Systems Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program in Japan (D.M. and T. A. K.), (3) Innovative Areas ?Glia Assembly? and ?Will Dynamics? of The Ministry of Education, Culture, Sports, Science, and Technology, Japan (25117011 to S.K.; 16H06403 to T.A.K.), (4) The Japan Agency for Medical Research and Development (AMED) (Yugo-Nou JP18dm0107095 to T.A.K.: Seishin-Syogai Taisaku-Jigyo JP18dk0307075 to S.K. and T.A.K.), (5) Young Principal Investigators' Research Grant of Innovation Center for Medical Redox Navigation, Kyushu University (to T.A.K.), (6) Takeda Medical Research Foundation (to T.A.K.), and (7) the SENSHIN Medical Research Foundation (to T.A.K., M.O., and S.K.). The funders had no role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript. We acknowledge the excellent technical assistance provided by Ms. Ayaka Maeda, Ms. Yuka Matsushita, Mr. Shogo Inamine and Ms. Aya Yamada.
PY - 2019/8
Y1 - 2019/8
UR - http://www.scopus.com/inward/record.url?scp=85071351600&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85071351600&partnerID=8YFLogxK
U2 - 10.1016/j.schres.2019.06.010
DO - 10.1016/j.schres.2019.06.010
M3 - Letter
C2 - 31296416
AN - SCOPUS:85071351600
VL - 210
SP - 326
EP - 328
JO - Schizophrenia Research
JF - Schizophrenia Research
SN - 0920-9964
ER -